Literature DB >> 24277466

Investigation on XRCC1 genetic polymorphism and its relationship with breast cancer risk factors in Chinese women.

Luming Zheng1, Feng Yang, Xukui Zhang, Jian Zhu, Pen Zhou, Fang Yu, Lei Hou, Guowei Zhao, Qingqing He, Baocheng Wang.   

Abstract

Breast cancer (BC) remains one of the most common cancers among women. The human X-ray repair cross-complementing 1 (XRCC1) gene plays key roles in base excision repair, and genetic polymorphisms of XRCC1 may be associated with the susceptibility to BC. This study aimed to evaluate the relationship between the XRCC1 genetic polymorphisms and BC susceptibility. A total of 354 BC patients and 366 cancer-free controls were enrolled in this study. Data about the risk factors of BC were collected using questionnaires. The XRCC1 genetic polymorphism was determined using created restriction site-polymerase chain reaction (CRS-PCR) and DNA sequencing methods. No significant differences in the allelic and genotypic frequencies of c.1804C>A genetic polymorphism were detected between cases and controls. The distributions of BC patients' risk factors were not significantly different between CC, CA, and AA genotypes. These findings indicate that the c.1804C>A genetic polymorphism of XRCC1 gene is not significantly associated with BC susceptibility in the Chinese women.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24277466     DOI: 10.1007/s12032-013-0738-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  34 in total

Review 1.  XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis.

Authors:  Huihua Li; Tam Cam Ha; Bee Choo Tai
Journal:  Breast       Date:  2009-05-14       Impact factor: 4.380

2.  Modification of enzymatically amplified DNA for the detection of point mutations.

Authors:  A Haliassos; J C Chomel; L Tesson; M Baudis; J Kruh; J C Kaplan; A Kitzis
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

3.  A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer.

Authors:  Li Liu; Peng Yuan; Li Liu; Chen Wu; Xiaomin Zhang; Huan Guo; Rong Zhong; Yihua Xu; Jing Wu; Shengyu Duan; Rui Rui; Tangchun Wu; Shaofa Nie; Xiaoping Miao; Dongxin Lin
Journal:  Breast Cancer Res Treat       Date:  2010-06-13       Impact factor: 4.872

4.  Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer.

Authors:  Priya Chacko; Balakrishnan Rajan; Thomas Joseph; Beela Sarah Mathew; M Radhakrishna Pillai
Journal:  Breast Cancer Res Treat       Date:  2005-01       Impact factor: 4.872

5.  Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients.

Authors:  Ugur Deligezer; Nejat Dalay
Journal:  Exp Mol Med       Date:  2004-12-31       Impact factor: 8.718

6.  No association between XRCC1 and XRCC3 gene polymorphisms and breast cancer risk: Iowa Women's Health Study.

Authors:  Bharat Thyagarajan; Kristin E Anderson; Aaron R Folsom; David R Jacobs; Charles F Lynch; Archana Bargaje; Waseem Khaliq; Myron D Gross
Journal:  Cancer Detect Prev       Date:  2006-09-11

7.  Genetic polymorphisms of XRCC1 (codon 399) and susceptibility to breast cancer in Iranian women, a case-control study.

Authors:  Mostafa Saadat; Leila Kohan; Shahpour Omidvari
Journal:  Breast Cancer Res Treat       Date:  2007-11-07       Impact factor: 4.872

Review 8.  Breast cancer in Iran: an epidemiological review.

Authors:  Seyed Mohsen Mousavi; Ali Montazeri; Mohammad Ali Mohagheghi; Alireza Mousavi Jarrahi; Iraj Harirchi; Masomeh Najafi; Mandana Ebrahimi
Journal:  Breast J       Date:  2007 Jul-Aug       Impact factor: 2.431

9.  DNA repair gene polymorphisms and susceptibility to familial breast cancer in a group of patients from Campinas, Brazil.

Authors:  Rozany Mucha Dufloth; Sandra Costa; Fernando Schmitt; Luiz Carlos Zeferino
Journal:  Genet Mol Res       Date:  2005-12-30

10.  Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China.

Authors:  Lei Fan; Ying Zheng; Ke-Da Yu; Guang-Yu Liu; Jiong Wu; Jin-Song Lu; Kun-Wei Shen; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  Breast Cancer Res Treat       Date:  2009-01-20       Impact factor: 4.872

View more
  1 in total

1.  Meta-analysis of XRCC1 polymorphism and risk of female reproductive system cancer.

Authors:  Na-Na Yang; Ying-Fan Huang; Jian Sun; Ying Chen; Zhong-Min Tang; Jin-Fang Jiang
Journal:  Oncotarget       Date:  2017-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.